Chee-Seng Tan

815 total citations
4 papers, 522 citations indexed

About

Chee-Seng Tan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chee-Seng Tan has authored 4 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Chee-Seng Tan's work include Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Chee-Seng Tan is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer therapeutics and mechanisms (1 paper). Chee-Seng Tan collaborates with scholars based in Singapore, United Kingdom and United States. Chee-Seng Tan's co-authors include Simon Pacey, David Gilligan, Nesaretnam Barr Kumarakulasinghe, Ross A. Soo, Yiqing Huang, Boon-Cher Goh, Tanya Trippett, Paul A. Meyers, Y Elisseyeff and Albert Kheradpour and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Molecular Cancer.

In The Last Decade

Chee-Seng Tan

4 papers receiving 521 citations

Peers

Chee-Seng Tan
Shigenari Nukaga Japan
J. Zugazagoitia Spain
Masaru Jida Japan
Shuhang Wang China
Lucía Regales United States
Dan Chan United States
Keita Masuzawa Japan
Kim-Son H. Nguyen United States
Annamaria Siggillino Italy
Qinfang Deng China
Shigenari Nukaga Japan
Chee-Seng Tan
Citations per year, relative to Chee-Seng Tan Chee-Seng Tan (= 1×) peers Shigenari Nukaga

Countries citing papers authored by Chee-Seng Tan

Since Specialization
Citations

This map shows the geographic impact of Chee-Seng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chee-Seng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chee-Seng Tan more than expected).

Fields of papers citing papers by Chee-Seng Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chee-Seng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chee-Seng Tan. The network helps show where Chee-Seng Tan may publish in the future.

Co-authorship network of co-authors of Chee-Seng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Chee-Seng Tan. A scholar is included among the top collaborators of Chee-Seng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chee-Seng Tan. Chee-Seng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Tan, Chee-Seng, et al.. (2018). Third generation EGFR TKIs: current data and future directions. Molecular Cancer. 17(1). 29–29. 195 indexed citations
2.
Tan, Chee-Seng, David Gilligan, & Simon Pacey. (2015). Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer. The Lancet Oncology. 16(9). e447–e459. 315 indexed citations
3.
Tan, Chee-Seng, Janette L. Vardy, Hongmei Xu, et al.. (2011). The role of gender in predicting for reduced drug clearance and increased toxicity in non-small cell lung cancer (NSCLC) patients receiving carboplatin and paclitaxel.. Journal of Clinical Oncology. 29(15_suppl). 7557–7557. 1 indexed citations
4.
Tan, Chee-Seng, Norma Wollner, Tanya Trippett, et al.. (1994). Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies.. Journal of Clinical Oncology. 12(9). 1955–1962. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigenari Nukaga Breakdown of academic impact, for papers by J. Zugazagoitia Breakdown of academic impact, for papers by Masaru Jida Breakdown of academic impact, for papers by Shuhang Wang Breakdown of academic impact, for papers by Lucía Regales Breakdown of academic impact, for papers by Dan Chan Breakdown of academic impact, for papers by Keita Masuzawa Breakdown of academic impact, for papers by Kim-Son H. Nguyen Breakdown of academic impact, for papers by Annamaria Siggillino Breakdown of academic impact, for papers by Qinfang Deng
Rankless by CCL
2026